Aletta
par Vitestro
Aletta is an autonomous robotic phlebotomy device that draws diagnostic blood samples in hospital blood-collection departments, for patients aged 16 and over. The vendor says it uses near-infrared imaging, ultrasound and Doppler to find a suitable vein and tell veins from arteries, and AI guidance with robotics to position and insert the needle; it then fills the sample tubes and applies a bandage, using a new sterile needle for each patient. A trained phlebotomist decides which patients are suitable, oversees the procedure and can supervise up to three devices, and the patient can press a stop or help button at any time. Aletta was CE-marked under the MDR in July 2024 and received FDA De Novo authorisation in August 2026; the vendor describes it as in clinical and pre-commercial use in Europe, starting with a limited release at selected hospitals. The vendor does not publish the device class or say whether any data leave the device.
Score de transparence
Pondéré sur quatre piliers · mis à jour le October 20, 2026
Capacités
Informations sur le fournisseur
Informations complètes sur le fournisseur/prestataire de cette application IA
Informations fournisseur (Règlement IA de l’UE)
Obtenez des informations sur les risques en exécutant des évaluations sur cette application IA.
Vous travaillez chez Vitestro ? Revendiquez cette fiche pour corriger ou compléter les données.
Prêt à gérer vos applications IA ?
Suivez, évaluez et gouvernez vos applications IA avec Anove.